ADIPOCHEM Trademark

Trademark Overview


On Tuesday, April 8, 2014, a trademark application was filed for ADIPOCHEM with the United States Patent and Trademark Office. The USPTO has given the ADIPOCHEM trademark a serial number of 86246364. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 4, 2022. This trademark is owned by Adipogen International, Inc.. The ADIPOCHEM trademark is filed in the Chemical Products, Pharmaceutical Products, Advertising, and Business and Retail Services categories with the following description:

Biological preparations for diagnostic purposes; Chemical reagents for medical or veterinary purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of polyclonal and monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes; Diagnostic reagents for medicinal use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids or cell cultures; Medical diagnostic reagents; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of obesity and diabetes and inflammatory disorders, for use in angiogenesis, dermatology, oncology, hematology and in tissue and organ transplantation, in ophth...

on-line retail store services featuring life science reagents; providing consumer product pricing information, and original manufacturers' information on product pricing to purchasing organizations and individual life science customers featuring life science reagents provided via an online computer network

Assays for research purposes; Biochemical and chemical reagents for research purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemicals, namely, polypeptides for in vitro research use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting enzymes and proteins for laboratory or research use; Chemicals for use in the purification of proteins for in vitro use; Diagnostics, namely, diagnostic preparations and reagents other than for medical or veterinary purposes; Diagnostic preparations and reagents for scientific or research use; Diagnostic preparations and reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Protein arrays and nucleotide arrays for scientific and medical research; Reagent for chemical analyses; Reagents for scientific or medical research use; Reagents for use in scientific appa...
adipochem

General Information


Serial Number86246364
Word MarkADIPOCHEM
Filing DateTuesday, April 8, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 4, 2022
Registration Number4780051
Registration DateTuesday, July 28, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 12, 2015

Trademark Statements


Goods and ServicesBiological preparations for diagnostic purposes; Chemical reagents for medical or veterinary purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of polyclonal and monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes; Diagnostic reagents for medicinal use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids or cell cultures; Medical diagnostic reagents; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of obesity and diabetes and inflammatory disorders, for use in angiogenesis, dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and natural medicinal extracts derived from animal, plant and microorganism sources for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, obesity and diabetes, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Reagents and media for medical diagnostic and veterinary diagnostic purposes; Antibiotics for research purposes
Pseudo MarkADIPO CHEM
Goods and Serviceson-line retail store services featuring life science reagents; providing consumer product pricing information, and original manufacturers' information on product pricing to purchasing organizations and individual life science customers featuring life science reagents provided via an online computer network
Goods and ServicesAssays for research purposes; Biochemical and chemical reagents for research purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemicals, namely, polypeptides for in vitro research use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting enzymes and proteins for laboratory or research use; Chemicals for use in the purification of proteins for in vitro use; Diagnostics, namely, diagnostic preparations and reagents other than for medical or veterinary purposes; Diagnostic preparations and reagents for scientific or research use; Diagnostic preparations and reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Protein arrays and nucleotide arrays for scientific and medical research; Reagent for chemical analyses; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Stem cell reagents for research purposes; Testing kits containing peptide substrates used in analyzing and detecting proteins, enzymes and receptors for laboratory or research use; Testing kits containing peptide substrates used in analyzing and detecting proteins, enzymes and receptors for clinical or medical laboratory use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 4, 2022
Primary Code001
First Use Anywhere DateFriday, March 1, 2013
First Use In Commerce DateFriday, March 1, 2013

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 4, 2022
Primary Code005
First Use Anywhere DateFriday, March 1, 2013
First Use In Commerce DateFriday, March 1, 2013

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 4, 2022
Primary Code035
First Use Anywhere DateFriday, March 1, 2013
First Use In Commerce DateFriday, March 1, 2013

Trademark Owner History


Party NameADIPOGEN LIFE SCIENCES, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121

Party NameAdipogen International, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameAdipogen International, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameAdipogen International, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Friday, February 4, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, July 28, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, August 9, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 28, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, May 12, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 12, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 22, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 3, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 1, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 31, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, March 31, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 31, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, March 31, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, January 23, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, January 23, 2015FINAL REFUSAL E-MAILED
Friday, January 23, 2015FINAL REFUSAL WRITTEN
Saturday, January 17, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 16, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 16, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 16, 2014COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Wednesday, July 16, 2014ASSIGNED TO LIE
Wednesday, July 16, 2014NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, July 16, 2014EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, July 16, 2014EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, July 16, 2014ASSIGNED TO EXAMINER
Wednesday, April 23, 2014NOTICE OF PSEUDO MARK E-MAILED
Tuesday, April 22, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 11, 2014NEW APPLICATION ENTERED IN TRAM